BSECompany Update6 Oct 2026 · 6 Oct 2026, 10:43 am

PFA

Shree Ganesh Biotech (India) Ltd · 539470

✦ AI Summary

Shree Ganesh Biotech (India) Ltd has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

f3b4fe26-7b3d-43c8-9b4a-4bb2a62b6a9b.pdf

pdf

Download →
View document text
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar Date:06.10.2026 To, To, To, Listing Department, The Secretary, Head - Listing BSE Limited, . The Calcutta Stock Exchange Ltd, Metropolitan Stock P J Tower, Dalal Street 7, Lyons Range, Exchange of India Limited Mumbai-400001 Kolkata - 700001 Vibgyor Towers, 4th floor, Plot Noe 62, Opp . .Trident Hotel Bandra Kurla Complex, Bandra (E) Mumbai - 400098 Scrip Code: 539470 Scrip Code: 29221 Scrip Code-SHREEGANES SUB: Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 30th September 2026. Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we herewith submit certificate from Satellite Corporate Services Private Limited, Registrar & Share Transfer Agent of the Company for the quarter ended on 30th September 2026. This is for your information and records. Thanking You. FOR, SHREE GANESH BIO-TECH (INDIA)LIMITED AMAN PATEL DIRECTOR Copy To: 1. National Securities Depository Ltd., Trade World, A wing, 4th Floor, Kamala Mills Compound, Lower Parel, Mumbai – 400013 2. Central Depository Services (India) Ltd, Marathon Futurex, A-Wing, 25th floor, NM Joshi Marg, Lower Parel, Mumbai 400013 Date: 05.10.2026 SHREE GANESH BIOTECH (INDIA) LTD CUBICLE NO 126,3/2, 75C, PARK STREET ,3RD FLOOR KAMDHENU BUILDING KOLKATA‐700016,WEST BENGAL Subject: Certificate under Regulation 74(5) of the SEBI (Depository and participants) Regulations, 2018 for the quarter ended 30th September 2026. Dear Sir/Madam, In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026.,, w.r.t. physical shares certificates received for dematerialization of securities (Equity Shares) of the Company, “Shree Ganesh Biotech (India) Ltd”.We hereby confirm and certify the following: a) The securities comprised in the said certificate(s) have been listed on the Stock Exchanges. b) The said certificate(s) after due verification have been mutilated and cancelled and the name of depository has been substituted in our records as registered owner. However in case of Shree Ganesh Biotech (India) Ltd no physical certificates are received for demat during the quarter ended 30th September 2026. This is for you information and records. Thanking you, For Satellite Corporate Services Pvt. Ltd. Michael Monteiro (Director)